Most Viewed Articles - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Most Viewed Articles

Novartis Invests US$500 Million in New Biologics Facility in Singapore

October 31, 2012

Novartis is investing more than half a billion US dollars in the construction of a new state-of-the-art biotechnology production site in Singapore for the manufacturing of drugs based on cell culture technology.

Third-Quarter 2012 Financial Reports Show Novartis and Merck Down

October 30, 2012

ePT--the Electronic Newsletter of Pharmaceutical Technology

Pharmaceutical industry leaders Novartis and Merck—among others—released second-quarter 2012 results showing global sales down in third-quarter 2012, with growth in key pharmaceutical products helping to offset losses due to patent expirations.

FDA Issues 483 to New England Compounding Center

October 29, 2012

ePT--the Electronic Newsletter of Pharmaceutical Technology

New England Compounding Center gets 483 after linked fungal meningitis outbreak.

New USP Standards Guide Prescription Container Labels

October 16, 2012

ePT--the Electronic Newsletter of Pharmaceutical Technology

New US Pharmacopeial Convention standards provide a universal approach to organizing labels for prescription containers dispensed by US pharmacists in an effort to improve patient understanding.

Novasep to Build the World's Largest Chromatography Plant

October 15, 2012

ePT--the Electronic Newsletter of Pharmaceutical Technology

Novasep announced that it will be investing EUR 30 million ($39 million) to build what will be the world's largest chromatography plant for the production of large volumes of commercial APIs.

Merck Plans to Move Global Headquarters within New Jersey

October 9, 2012

ePT--the Electronic Newsletter of Pharmaceutical Technology

Merck has announced plans to close its headquarters in Whitehouse Station, New Jersey, and relocate to its existing facility in Summit, New Jersey, beginning in 2014.

Meningitis Outbreak Linked to Contaminated Vials of Steroid Injectables

October 9, 2012

ePT--the Electronic Newsletter of Pharmaceutical Technology

A national fungal meningitis outbreak linked to contaminated vials of steroid injectables from a Massachusetts compounding operation has reignited the debate over the safety of compounded drugs and the need for stronger FDA regulation of these activities. Last week, the Centers for Disease Control and Prevention reported seven deaths and 91 ill.

Merck Serono Launches New Spin-off Company; Provides Update on Restructuring

October 3, 2012

ePT--the Electronic Newsletter of Pharmaceutical Technology

Merck Serono's Asceneuron is the third company to be spun off from the company's Entrepreneur Partnership Program that was launched to mitigate the impact from recent restructuring at its Geneva site.

Pharma Majors Build Manufacturing Capacity in Russia

October 3, 2012

PTSM: Pharmaceutical Technology Sourcing and Management

Several Big Pharma companies strengthen their manufacturing presence in Russia.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
Which of the following business challenge poses the greatest threat to your company?
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
Building a sustainable pipeline of products
26%
Attracting a skilled workforce
29%
Obtaining/maintaining adequate financing
14%
Regulatory compliance
31%
View Results
Eric Langer Outsourcing Outlook Eric LangerBiopharma Outsourcing Activities Update
Cynthia Challener, PhD Ingredients Insider Cynthia Challener, PhDAppropriate Process Design Critical for Commercial Manufacture of Highly Potent APIs
Jill Wechsler Regulatory Watch Jill Wechsler FDA and Manufacturers Seek a More Secure Drug Supply Chain
Sean Milmo European Regulatory WatchSean MilmoQuality by Design?Bridging the Gap between Concept and Implementation
Click here